Metabolic Safety: IGF-1 and Glucose Effects One of the most clinically significant safety findings relates to AOD-9604s metabolic profile, particularly its lack of effects on insulin-like growth factor-1 (IGF-1) and glucose metabolism
Preclinical and early human data suggest it may promote lipolysis, inhibit lipogenesis, and preferentially act on adipose tissue by influencing beta3 adrenergicmediated pathways and hormonesensitive lipase activity
Increased GLUT4 transporter expression means more glucose can move from the bloodstream into muscle cells, where it can be used for energy or stored as glycogen
Standard Dosing Ranges: The typical dosage range for AOD-9604 varies depending on route of administration
Rapid Relief from Symptoms Injections fix deficiency symptoms very quickly
To take AOD 9604, there are two prescribed methods: Consult with your doctor about taking this medication with other supplements or medications